Silicon Valley billionaires including Bezos, Thiel, and Altman are investing in cellular reprogramming startups to reverse aging. Life Biosciences completed the first human trial, treating three glaucoma patients with an experimental eye injection and antibiotics; two showed vision improvements with no major side effects reported. The technique, proven effective in animals, could potentially address multiple age-related diseases if further clinical trials succeed.